Chagas disease is independently associated with brain atrophy

Journal of Neurology
|April 14, 2009
PubMed

Insights

Chagas disease (CD) is linked to brain atrophy, independent of heart issues. This brain volume loss, not infarcts, may explain cognitive decline in Chagas disease patients.

Area of Science:

  • Neurology
  • Cardiology
  • Infectious Diseases

Background:

  • Chagas disease (CD) is a significant cause of heart disease and stroke.
  • Brain involvement in CD is often linked to cardiac dysfunction causing ischemia or emboli.
  • Cognitive impairment in CD may occur independently of cardiac pathology.

Discussion:

  • This study compared head CT findings in Chagas disease cardiomyopathy (CDC) versus other cardiomyopathies (OC).
  • Brain atrophy, characterized by smaller total brain volume, was observed in CDC patients.
  • The prevalence of brain infarcts did not differ between groups.

Key Insights:

  • Chagas disease is an independent predictor of brain atrophy.
  • Brain atrophy, not infarcts, appears to be the primary anatomical cause of cognitive impairment in Chagas disease.
  • Total brain volume was significantly smaller in CDC patients compared to OC patients.

Outlook:

  • Further research should explore the mechanisms linking Chagas disease to brain atrophy.
  • Investigating therapeutic strategies targeting brain atrophy in Chagas disease is warranted.
  • Understanding the neurobiological impact of Chagas disease can improve patient management and outcomes.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...